Investors Should Prepare for a Rough Start to 2023
Wednesday's poor ADP Jobs Report portends things to come.
Will Salesforce Earnings Generate a Rally?
Let's see what the charts and indicators say ahead of the report.
CrowdStrike Gets CrowdStruck, But I Have a Long-Term Investment Plan
The cybersecurity provider's latest results don't look bad at all.
Intra-Cellular Therapies Has My Attention
We have two price targets.
Welcome to Part 2 of My 2023 Tax Loss Selling Recovery Portfolio
This quartet of stocks includes a boat retailer, an underwear maker, a department store chain and an entertainment giant.
Another Major Index Turns Neutral From Bullish
The market is likely going through a consolidation of the notable gains from the October lows
Can IBM's Upside Breakout Continue?
Possibly, as a number of Big Blue's technical signals are bullish.
Biogen Surges on Alzheimer's Drug News: How to Play the Stock
Let's see how traders could react to the latest news.
As Much as It May Kill Most Traders, It Isn't a Bad Time to Sit on Your Hands
Whenever you need to search high and low to find a few tradable stocks, it usually is best to reduce your activity dramatically.
Jiang Zemin's Death Overshadows Jack Ma's Tokyo Residency
The day's initial focus was on the Alibaba entrepreneur's extended stay in Japan before word broke that China's former president has died at 96.